No Photo Available

Last Update

2017-02-12T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong David Karpf?

Dr. David B. Karpf MD

Adj. Clinical Professor of Endocrinology

Stanford University

Direct Phone: (650) ***-****       

Email: d***@***.edu

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Stanford University School of Medicine

Stanford University

857 Serra Street, Suite 210

Stanford, California 94305

United States

Company Description

Stanford University, located between San Francisco and San Jose in the heart of California's Silicon Valley, is one of the world's leading teaching and research universities. Since its opening in 1891, Stanford has been dedicated to finding solutions to b ... more

Find other employees at this company (51,214)

Background Information

Employment History

Chief Medical Officer

Virobay Inc

Chief Medical Officer and Vice President, Clinical Affairs

Metabolex , Inc.

Executive Director of Clinical Research and Regulatory Affairs

Geron Corporation

Vice President of Clinical and Regulatory Affairs

Calydon , Inc.

Director of Clinical Research At Research Laboratories

Merck & Co. , Inc.

Faculty

University of California , San Francisco

Executive Director of Clinical Research

Hoffmann-La Roche Inc.

Executive Medical Director for Oncology

2001--Geron Corporation

Education

Stanford University School of Medicine

UCSF School of Medicine

B.A.

Psychology and Biology

University of California , Berkeley

M.D.

M.D. degree

University of California , San Diego

MD

Johns Hopkins

MD

UC San Diego Medical School

degrees

Biology and Psychology

University of California , Berkeley

Web References (70 Total References)


David B. Karpf, ...

americanbonehealth.org [cached]

David B. Karpf, MD,

...
David B. Karpf, MD,
...
David B. Karpf, MD,
...
David B. Karpf, MD,
President of the Medical & Scientific Advisory Board
Dr. Karpf is an adjunct clinical professor of endocrinology at Stanford University School of Medicine, where he sees patients with osteoporosis and metabolic bone disease. He is board certified in internal medicine with a subspecialty in endocrinology and metabolism. A UC Berkeley graduate, Dr. Karpf received his medical degree from UC San Diego and completed residency in internal medicine and fellowship in endocrinology, diabetes and metabolism at UCLA/Cedars-Sinai Medical Center. This was followed by a fellowship in metabolic bone disease in the endocrine bone unit at UCSF, where his bench research focused on characterization and isolation of the PTH/PTHrP receptor.


ViroBay

www.virobayinc.com [cached]

David B. Karpf MD Chief Medical Officer

...
David B. Karpf MD Chief Medical Officer
David B. Karpf, M.D. has served as our Chief Medical Officer since October 2011. From December 2010 to October 2011, Dr. Karpf served as a life sciences consultant. From January 2004 to December 2010, Dr. Karpf served as Chief Medical Officer and Vice President of Clinical Affairs at Metabolex, Inc., now CymaBay Therapeutics, Inc., where he oversaw the development of clinical programs in various diseases, including type 2 diabetes, gout and dyslipdemia. From May 2001 to January 2004, Dr. Karpf served as Executive Director of Clinical Research and Regulatory Affairs at Geron Corporation, or Geron, a clinical stage biopharmaceutical company, where he oversaw early clinical programs in cancer and regenerative medicine. From May 2000 to May 2001, Dr. Karpf served as Vice President, Clinical and Regulatory Affairs at Calydon, Inc., a company that developed oncolytic virus cancer treatments, which was acquired by Cell Genesis, Inc. in September 2001. From October 1996 to May 2000, Dr. Karpf served as Executive Director of Clinical Research at Roche, where he was responsible for clinical development activities in endocrinology and metabolic bone disease. From August 1991 to December 1996, Dr. Karpf served as Director of Clinical Research at Merck Research Laboratories, where he played a pivotal role in the successful New Drug Application and launch of Fosamax™. Dr. Karpf has also held several academic positions and is currently an adjunct clinical professor of endocrinology at Stanford University School of Medicine. Dr. Karpf received a B.A. in Psychology and Biology from University of California, Berkeley and an M.D. from University of California, San Diego. He completed a residency in Internal Medicine and a fellowship in Endocrinology, Diabetes and Metabolism at University of California, Los Angeles School of Medicine and Cedars-Sinai Medical Center, and a post-doctoral fellowship in the Endocrine Unit at University of California, San Francisco School of Medicine.


Medical & Scientific Advisory Board

www.americanbonehealth.org [cached]

David Karpf picture

...
David Karpf, MD, President, Medical and Scientific Advisory
Dr. Karpf is an adjunct clinical professor of endocrinology at Stanford University School of Medicine, where he sees patients with osteoporosis and metabolic bone disease. He is board certified in internal medicine with a subspecialty in endocrinology and metabolism. A UC Berkeley graduate, Dr. Karpf received his medical degree from UC San Diego and completed residency in internal medicine and fellowship in endocrinology, diabetes and metabolism at UCLA/Cedars-Sinai Medical Center. This was followed by a fellowship in metabolic bone disease in the endocrine bone unit at UCSF, where his bench research focused on characterization and isolation of the PTH/PTHrP receptor.


Dr. David Karpf joins ...

www.americanbonehealth.org [cached]

Dr. David Karpf joins Medical and Scientific Advisory Board Details Created on 07-31-2013

David Karpf picture Dr. Karpf is an adjunct clinical professor of endocrinology at Stanford University School of Medicine, where he sees patients with osteoporosis and metabolic bone disease. He is board certified in internal medicine with a subspecialty in endocrinology and metabolism.
A UC Berkeley graduate, Dr. Karpf received his medical degree from UC San Diego and completed residency in internal medicine and fellowship in endocrinology, diabetes and metabolism at UCLA/Cedars-Sinai Medical Center. This was followed by a fellowship in metabolic bone disease in the endocrine bone unit at UCSF, where his bench research focused on characterization and isolation of the PTH/PTHrP receptor.
Dr. Karpf was on the bone-endocrine faculty at UCSF until 1991, when he was recruited to Merck to run the fracture trials with the osteoporosis medication Fosamax. He has conducted numerous clinical trials and authored more than 27 peer-reviewed publications. Since 1997 he has attended in the osteoporosis clinic at Stanford University Hospital and Clinics, where he sees patients with osteoporosis and other metabolic bone disease and teaches the house staff.


What's New

www.americanbonehealth.org [cached]

David Karpf picture Dr. Karpf is an adjunct clinical professor of endocrinology at Stanford University School of Medicine, where he sees patients with osteoporosis and metabolic bone disease. He is board certified in internal medicine with a subspecialty in endocrinology and metabolism.

A UC Berkeley graduate, Dr. Karpf received his medical degree from UC San Diego and completed residency in internal medicine and fellowship in endocrinology, diabetes and metabolism at UCLA/Cedars-Sinai Medical Center. This was followed by a fellowship in metabolic bone disease in the endocrine bone unit at UCSF, where his bench research focused on characterization and isolation of the PTH/PTHrP receptor.
Dr. Karpf was on the bone-endocrine faculty at UCSF until 1991, when he was recruited to Merck to run the fracture trials with the osteoporosis medication Fosamax. He has conducted numerous clinical trials and authored more than 27 peer-reviewed publications. Since 1997 he has attended in the osteoporosis clinic at Stanford University Hospital and Clinics, where he sees patients with osteoporosis and other metabolic bone disease and teaches the house staff.

Similar Profiles

Other People with this Name

Other people with the name Karpf

Gord Karpf
Canada Cartage System Ltd

Sylvia Karpf
National Association for College Admission Counseling

Lola Karpf
University of Sussex

Carol Karpf
Wilbanks Partners , LLC

Nancy Karpf
DavidsonKempner Capital Management LP

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory